NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
1 clinical trials · Condition
◉ Watch NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
| Record | Firm | Date |
|---|---|---|
| Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study (NCT03872427) | National Cancer Institute (NCI) | 2019-12-14 |
Track NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor automatically
Every clearance here is in the API, with alerts when new ones post.